These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10997087)

  • 41. Short-term tumor cell lines from renal cell carcinoma for use as autologous tumor cell vaccines in the treatment of kidney cancer.
    Dillman RO; Beutel LD; Cornforth AN; Nayak SK
    Cancer Biother Radiopharm; 2000 Apr; 15(2):161-8. PubMed ID: 10803321
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid improvement in pain and functional level in a patient with metastatic renal cell carcinoma: a case report and review of the literature.
    Hird AE; Chow E; Ehrlich L; Probyn L; Sinclair E; Yip D; Ko YJ
    J Palliat Med; 2008 Oct; 11(8):1156-61. PubMed ID: 18980461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case of posttherapeutic sclerotic change of bone metastasis from renal cell carcinoma which proved histopathologically to be complete response.
    Shimizu TS; Uchida T; Shibata Y; Satoh J; Sugihara S; Maehara Y
    Urol Int; 1994; 53(3):172-5. PubMed ID: 7645148
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Remarkable responses of metastatic renal cell cancer in multiple organs treated with alpha-interferon.
    Takita T; Tanaka J; Murase T; Shimoji T; Mitsuya H
    J Urol; 1986 Nov; 136(5):1061-2. PubMed ID: 3773069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lingual metastasis from renal cell carcinoma management and review of the literature.
    Goel MC; Williams DW; Evans H; Roberts JG
    Urol Int; 2003; 71(4):418-21. PubMed ID: 14646444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The health care burden of skeletal related events in patients with renal cell carcinoma and bone metastasis.
    Antczak C; Trinh VQ; Sood A; Ravi P; Roghmann F; Trudeau V; Chang SL; Karakiewicz PI; Kibel AS; Krishna N; Nguyen PL; Saad F; Sammon JD; Sukumar S; Zorn KC; Sun M; Trinh QD
    J Urol; 2014 Jun; 191(6):1678-84. PubMed ID: 24384157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeted therapy for metastatic renal cell cancer.
    Verbaeys C; Hoebeke P; Van Belle S; Rottey S
    Acta Clin Belg; 2010; 65(2):115-21. PubMed ID: 20491361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Systemic therapy approaches in patients with bone metastases of urogenital malignancies].
    Finter F; Mottaghy FM; Kuefer R; Hautmann RE; Rinnab L
    Urologe A; 2007 Aug; 46(8):904, 906-12. PubMed ID: 17639296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rationale for immunotherapy of renal cell carcinoma.
    Heicappell R; Ackermann R
    Urol Res; 1990; 18(6):357-72. PubMed ID: 2100410
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma.
    Grünwald V; Eberhardt B; Bex A; Flörcken A; Gauler T; Derlin T; Panzica M; Dürr HR; Grötz KA; Giles RH; von Falck C; Graser A; Muacevic A; Staehler M
    Nat Rev Urol; 2018 Aug; 15(8):511-521. PubMed ID: 29904105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Metastasizing kidney cancer. Experience with interferon alfa-2a and vinblastine].
    González Enguita C; Roncalés Badal A; Gil Sanz MJ; Martínez Bengoechea J; Tello Royloa C; Rioja Sanz LA
    Actas Urol Esp; 1990; 14(5):335-8. PubMed ID: 2288249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nephrectomy for metastatic renal-cell cancer.
    Schwartz JD
    N Engl J Med; 2002 Apr; 346(14):1095-6. PubMed ID: 11936125
    [No Abstract]   [Full Text] [Related]  

  • 53. Renal cell carcinoma.
    Rini BI; Campbell SC; Escudier B
    Lancet; 2009 Mar; 373(9669):1119-32. PubMed ID: 19269025
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treating patients with renal cell carcinoma and bone metastases.
    Guida A; Escudier B; Albiges L
    Expert Rev Anticancer Ther; 2018 Nov; 18(11):1135-1143. PubMed ID: 30183421
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A medical oncologist's approach to immunotherapy for advanced renal tumors: is nephrectomy indicated?
    Cooney MM; Remick SC; Vogelzang NJ
    Curr Urol Rep; 2004 Feb; 5(1):19-24. PubMed ID: 14733832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of osseous metastases secondary to renal cell carcinoma.
    Smith EM; Kursh ED; Makley J; Resnick MI
    J Urol; 1992 Sep; 148(3):784-7. PubMed ID: 1512825
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Current status of treatment of renal cell carcinoma and future problems].
    Satomi Y
    Nihon Hinyokika Gakkai Zasshi; 1990 Jan; 81(1):1-13. PubMed ID: 1689406
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Cardiac Metastasis in a Patient with Clear Cell Renal Cell Carcinoma who Underwent Multimodality Therapy for Multiple Metastases after Radical Nephrectomy].
    Takeuchi S; Mizutani K; Iinuma K; Muramatsu-Maekawa Y; Horie K; Kato T; Nakane K; Tsuchiya T; Nakano M; Koie T
    Hinyokika Kiyo; 2019 Jun; 65(6):197-201. PubMed ID: 31501385
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nephrectomy combined with perioperative alpha-interferon in the treatment of advanced local and minimally metastatic renal cell cancer.
    Cockerell OC; Oliver RT; Nethersall A
    Urol Int; 1991; 46(1):46-9. PubMed ID: 2024371
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Case of the month. Metastatic lesion on the humerus.
    Vocke TV
    JAAPA; 2012 Jul; 25(7):65. PubMed ID: 22894041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.